We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

WERFEN

Werfen provides diagnostic instruments for critical care and hemostasis to meet the testing needs of medical professi... read more Featured Products: More products

Download Mobile App




Werfen Completes Immucor Acquisition to Expand Leadership in Specialized Diagnostics

By LabMedica International staff writers
Posted on 16 Mar 2023
Print article
Image: Werfen had reached an agreement in November 2022 to acquire Immucor for USD 2 billion (Photo courtesy of Werfen)
Image: Werfen had reached an agreement in November 2022 to acquire Immucor for USD 2 billion (Photo courtesy of Werfen)

Werfen (Barcelona, Spain) has successfully completed the acquisition of Immucor, Inc. (Norcross, GA, USA) after receiving the required regulatory and antitrust approvals. In November 2022, Werfen reached an agreement to acquire Immucor, a privately held in vitro diagnostics (IVD) company with a strong presence in the global Transfusion and Transplant markets, for approximately USD 2 billion. The Transfusion and Transplant product lines complement Werfen's existing Hemostasis, Acute Care, and Autoimmunity business lines, expanding its portfolio of Specialized Diagnostic solutions for hospitals and clinical laboratories.

With the integration of Immucor, Werfen has expanded its presence as a company of reference in the Specialized Diagnostics market and grown its portfolio of diagnostic solutions for hospitals and clinical laboratories. Additionally, Werfen will have seven technology centers and employ more than 7,000 people worldwide; with a direct presence in over 30 countries and across more than 100 territories through distributors.

"During our more than 50-year history, we have demonstrated our strong commitment to expand our IVD business through organic growth, complemented with highly strategic acquisitions," said Carlos Pascual, CEO of Werfen.

Related Links:
Werfen 
Immucor, Inc. 

Platinum Supplier
Xylazine Immunoassay Test
Xylazine ELISA
New
Gold Supplier
HDL Subfractions Kit
Lipoprint HDL Subfractions Kit
New
Ferritin Test
Ferritin
New
CK-MB Rapid Test Cassette (Whole Blood/ Serum/ Plasma)
CK-MB Rapid Test

Print article
GLOBETECH PUBLISHING LLC

Channels

Clinical Chemistry

view channel
Image: The new assays are designed to run on the B•R•A•H•M•S KRYPTOR compact PLUS clinical chemistry analyzer (Photo courtesy of Thermo Fisher)

Breakthrough Immunoassays to Aid in Risk Assessment of Preeclampsia

Preeclampsia is a life-threatening blood pressure condition that can arise during pregnancy and the postpartum phase. This severe pregnancy complication is a primary cause of maternal and fetal mortality... Read more

Molecular Diagnostics

view channel
Image: The ClarityDX Prostate test can reduce unnecessary prostate biopsies by up to 35% (Photo courtesy of Nanostics)

Innovative Blood Test to Revolutionize Prostate Cancer Detection and Reduce Invasive Biopsies

One in six men will receive a prostate cancer diagnosis during their lives. Thankfully, if caught early, prostate cancer is highly treatable. However, the existing screening process has its limitations.... Read more

Hematology

view channel
Image: The latest FDA clearance has finally brought HemoScreen to its full potential as a true POC hematology analyzer (Photo courtesy of PixCell)

True POC Hematology Analyzer with Direct Capillary Sampling Enhances Ease-of-Use and Testing Throughput

An innovative 5-part differential Complete Blood Count (CBC) analyzer with direct capillary sampling capability significantly simplifies blood sampling and minimizes the pre-analytical process.... Read more

Immunology

view channel
Image: A new test could detect the body’s adaptive immune response to viruses (Photo courtesy of 123RF)

Predictive T-Cell Test Detects Immune Response to Viruses Even Before Antibodies Form

The adaptive immune system is an incredible defense mechanism that allows the human body to identify and mount targeted responses against specific pathogens. T-Cells, a special kind of white blood cell,... Read more

Microbiology

view channel
Image: On-chip pretreatment and rapid AST based directly on positive blood cultures (Photo courtesy of Liu Yang)

Integrated Solution for Rapid AST Directly From Positive Blood Cultures to Combat Bloodstream Infection

The presence of living bacteria in the bloodstream, known as bacteremia, can lead to serious conditions like bloodstream infections (BSIs) and sepsis, which can often be fatal. Quickly prescribing the... Read more

Pathology

view channel
Image: A new microscopy method detects treatment-resistant cancer cells early (Photo courtesy of 123RF)

New Rapid-Live Screening Microscopy Technique Enables Early Detection of Treatment-Resistant Cancer Cells

Chemotherapy serves as an effective tool in the fight against cancer, yet some cancer cells can evade treatment by going into a dormant state known as senescence. These so-called therapy-induced senescent... Read more

Technology

view channel
Image: A new electrochemical device can quickly and inexpensively identify people at greatest risk for osteoporosis (Photo courtesy of ACS Central Science, 2023)

Electrochemical Device Identifies People at Higher Risk for Osteoporosis Using Single Blood Drop

With the global increase in life expectancy, the incidence of age-related conditions like osteoporosis is increasing. Osteoporosis, affecting around 200 million individuals worldwide, has a higher incidence... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.